首頁 › 肥胖症 › 北卡羅來納州 › Greensboro
Greensboro, NC 的 肥胖症 臨床試驗
12 項針對 肥胖症 的研究正在 Greensboro（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Moses H Cone Memorial Hospital, Greensboro
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Medication Management /ID# 281965, Greensboro
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- Medication Management, LLC, Greensboro
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- PharmQuest Life Sciences LLC, Greensboro
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Medication Mgmnt, LLC_Grnsboro, Greensboro
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
招募中3 期
- PharmQuest Life Sciences LLC, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Medication Management, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- PharmQuest Life Sciences, LLC, Greensboro
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Medication Management, Greensboro
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Medication Management, Greensboro
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
招募中3 期
- PharmQuest, Greensboro
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
招募中3 期
- Kailera Clinical Site, Greensboro
其他城市的 肥胖症 試驗
- Houston, TX43 項研究
- Chicago, IL41 項研究
- New York City, NY40 項研究
- San Antonio, TX40 項研究
- Washington, DC33 項研究
- Orlando, FL32 項研究
- Dallas, TX30 項研究
- Boston, MA28 項研究
- Las Vegas, NV27 項研究
- Miami, FL27 項研究
- Baltimore, MD26 項研究
- Jacksonville, FL25 項研究
Greensboro 的其他研究
- 過重12 項研究
- 第二型糖尿病6 項研究
- 心臟衰竭6 項研究
- 乳癌5 項研究
- 心血管疾病5 項研究
- HIV4 項研究
- 中風4 項研究
- 間質性肺病4 項研究
- 心臟病發4 項研究
- 肺癌3 項研究
- 特發性肺纖維化3 項研究
- 動脈硬化3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。